Objective: To assess the variation in HIV-1 over the menstrual cycle, including RNA levels in the female genital tract, plasma HIV-1-RNA levels, CD4 cell counts, and culturable virus.
Design: A prospective analysis of 55 HIV-1-infected women.
Methods: Blood and genital tract specimens were collected weekly over 8 weeks, spanning two complete menstrual cycles.